FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

716068004: Evolocumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3304640011 Evolocumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3304641010 Evolocumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
923911000195111 evolocumab it Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
810781000172117 évolocumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Evolocumab (substance) Is a Antilipemic agent (substance) true Inferred relationship Some
Evolocumab (substance) Is a agent d'anticorps monoclonal false Inferred relationship Some
Evolocumab (substance) Is a Enzyme inhibitor false Inferred relationship Some
Evolocumab (substance) Is a Monoclonal antibody true Inferred relationship Some
Evolocumab (substance) Is a PCSK9 inhibitor true Inferred relationship Some
Evolocumab (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Proprotein convertase subtilisin/kexin type 9 inhibitor (disposition) true Inferred relationship Some
Evolocumab (substance) Is a Enzyme inhibitor protein true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing evolocumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Evolocumab (substance) Inferred relationship Some 1
Product containing evolocumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Evolocumab (substance) Inferred relationship Some 1
Product containing only evolocumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Evolocumab (substance) Inferred relationship Some 1
Product containing only evolocumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Evolocumab (substance) Inferred relationship Some 1
Evolocumab 140 mg/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Evolocumab (substance) Inferred relationship Some 1
Evolocumab 140 mg/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Evolocumab (substance) Inferred relationship Some 1
Evolocumab 120 mg/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Evolocumab (substance) Inferred relationship Some 1
Evolocumab 120 mg/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Evolocumab (substance) Inferred relationship Some 1

Reference Sets

Description inactivation indicator reference set

Back to Start